Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc (NASDAQ:NASDAQ:ONCT) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants James Breitmeyer – President & Chief Executive Officer...
Source: seekingalpha.com